Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Harold D. Doshan"'
Autor:
Arthur S. Slutsky, Walter J. Applin, Harold D. Doshan, Robert H. Brown, Frank S. Caruso, Richard R. Rosenthal
Publikováno v:
Journal of Cardiovascular Pharmacology. 8:S105-S108
Celiprolol, a new beta-adrenoceptor antagonist, blocks serotonin- and methacholine-mediated bronchoconstriction in animals, even in the presence of propranolol. In two, randomized, placebo-controlled, 5-way crossover trials, the pulmonary effects of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8d7a2109392e63807dc6c5a6e942986
https://doi.org/10.1097/00005344-198608004-00023
https://doi.org/10.1097/00005344-198608004-00023
Autor:
Matthias Pohl, H. Matthys, Herbert Braig, Harold D. Doshan, Walter J. Applin, Karl-Heinz Rühle
Publikováno v:
Journal of Cardiovascular Pharmacology. 8:S40-S42
The bronchopulmonary effects of celiprolol were studied in 12 male asthmatic patients who showed mean maximum changes of -24% in forced one-second expiratory volume (FEV1) and 130% in airways resistance (Raw) following a single, 80 mg dose of propran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0200d35e5c9b1fb06f2e4f774b0a252
https://doi.org/10.1097/00005344-198608004-00008
https://doi.org/10.1097/00005344-198608004-00008
Publikováno v:
Journal of cardiovascular pharmacology. 8
Sixteen normotensive asthmatic patients received single doses of 400 and 600 mg of celiprolol and 100 mg of atenolol in this placebo-controlled, double-blind crossover study. Pulmonary function was assessed by spirometry. Changes in forced one-second
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd7915658ddd77399dcb84ef28c8d9fb
https://pubmed.ncbi.nlm.nih.gov/2427837
https://pubmed.ncbi.nlm.nih.gov/2427837
Publikováno v:
Biochemical pharmacology. 27(14)
Amidines and guanidines have been reported to be effective inhibitors in vitro of complement. This study reports the in vivo activity of four such compounds, 4-aminobenzamidine, 3,4-dimethoxybenzamidine, 4-methyl-2-guanidinoquinazoline and pentamidin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd77480a5f3c181076cd4b10c1c89d9
https://pubmed.ncbi.nlm.nih.gov/708469
https://pubmed.ncbi.nlm.nih.gov/708469